Ernexa Therapeutics Inc.
ERNA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,240 | -$3,139 | -$8,202 | -$5,759 |
| Dep. & Amort. | $70 | $55 | $69 | $68 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $293 | $0 | $0 | $410 |
| Change in WC | -$21 | -$506 | $226 | -$1,426 |
| Other Non-Cash | -$374 | $1,058 | $5,842 | $3,162 |
| Operating Cash Flow | -$1,272 | -$2,532 | -$2,065 | -$3,545 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$22 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$22 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $2,250 | $0 |
| Stock Issued | $0 | $4,929 | $4 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $8 |
| Other Fin. Act. | $26 | $0 | $0 | $1,002 |
| Financing Cash Flow | $26 | $4,929 | $2,254 | $1,010 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,268 | $2,397 | $189 | -$2,535 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,315 | $1,918 | $1,729 | $4,264 |
| End Cash | $3,047 | $4,315 | $1,918 | $1,729 |
| Free Cash Flow | -$1,294 | -$2,532 | -$2,065 | -$3,545 |